Loading…

Diagnosis and differential diagnosis of MND/ALS: IFCN handbook chapter

•Accurate and rapid diagnosis of amyotrophic lateral sclerosis (ALS) is important to prevent erroneous interventions.•The recent Gold Coast criteria are easily applicable and have high sensitivity and specificity.•Future developments will help to distinguish ALS as a specific clinical-pathologic ent...

Full description

Saved in:
Bibliographic Details
Published in:Clinical neurophysiology practice 2024, Vol.9, p.27-38
Main Authors: de Carvalho, Mamede, Swash, Michael
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c391t-a7aeb296c96c04f42b13269ec9d543b2e5247c723b45b6a093a80f11c259af7d3
container_end_page 38
container_issue
container_start_page 27
container_title Clinical neurophysiology practice
container_volume 9
creator de Carvalho, Mamede
Swash, Michael
description •Accurate and rapid diagnosis of amyotrophic lateral sclerosis (ALS) is important to prevent erroneous interventions.•The recent Gold Coast criteria are easily applicable and have high sensitivity and specificity.•Future developments will help to distinguish ALS as a specific clinical-pathologic entity. Accurate and rapid diagnosis of amyotrophic lateral sclerosis (ALS) is essential in order to provide accurate information for patient and family, to avoid time-consuming investigations and to permit an appropriate management plan. ALS is variable regarding presentation, disease progression, genetic profile and patient reaction to the diagnosis. It is obviously important to exclude treatable conditions but, in most patients, for experienced neurologists the diagnosis is clear-cut, depending on the presence of progressive upper and lower motor neuron signs. Patients with signs of restricted lower motor neuron (LMN) or upper motor neuron (UMN) dysfunction may present diagnostic difficulty, but electromyography (EMG) is often a determinant diagnostic test since it may exclude other disorders. Transcranial magnetic stimulation may aid detection of UMN dysfunction, and brain and spinal cord MRI, ultrasound and blood neurofilament measurements, have begun to have clinical impact, although none are themselves diagnostic tests. Several sets of diagnostic criteria have been proposed in the past; all rely on clinical LMN and UMN signs in different anatomic territories, EMG changes, exclusion of other disorders, and disease progression, in particular evidence of spreading to other anatomic territories. Fasciculations are a characteristic clinical feature and increased importance is now attached to fasciculation potentials detected by EMG, when associated with classical signs of denervation and reinnervation. The Gold Coast diagnostic criteria rely on the presence of UMN and LMN signs in one (or more) anatomic territory, or LMN signs in two (or more) anatomic territories, recognizing the fundamental clinical requirements of disease progression and exclusion of other diseases. Recent studies confirm a high sensitivity without loss of specificity using these Gold Coast criteria. In considering the diagnosis of ALS a critical question for future understanding is whether ALS should be considered a syndrome or a specific clinico-pathologic entity; this can only be addressed in the light of more complete knowledge.
doi_str_mv 10.1016/j.cnp.2023.12.003
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_142a5acb970b497d983b683e3adfbff6</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2467981X23000355</els_id><doaj_id>oai_doaj_org_article_142a5acb970b497d983b683e3adfbff6</doaj_id><sourcerecordid>2917558212</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-a7aeb296c96c04f42b13269ec9d543b2e5247c723b45b6a093a80f11c259af7d3</originalsourceid><addsrcrecordid>eNp9UctOwzAQjBBIIOgHcMuRS4MfSRzDCRUKlQocAImbtXbW4JLGxQ5I_D0uBcQJabUPe2bW8mTZISUFJbQ-XhSmXxWMMF5QVhDCt7I9VtZiLBv6uP2n381GMS4IIVSQdd7LpucOnnofXcyhb_PWWYsB-8FBl4afK2_z65vz47P53Uk-m05u8ucE1t6_5OYZVgOGg2zHQhdx9F33s4fpxf3kajy_vZxNzuZjwyUdxiAANZO1SUFKWzJNOaslGtlWJdcMK1YKIxjXZaVrIJJDQyylhlUSrGj5fjbb6LYeFmoV3BLCh_Lg1NeBD08KwuBMh4qWDCowWgqiSyla2XBdNxw5tFZbWyeto43WKvjXN4yDWrposOugR_8WFZNUVFXDKEtQuoGa4GMMaH9XU6LWFqiFShaotQWKMpUsSJzTDQfTf7w7DCoah73B1gU0Q3qw-4f9CafJjHU</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2917558212</pqid></control><display><type>article</type><title>Diagnosis and differential diagnosis of MND/ALS: IFCN handbook chapter</title><source>Elsevier ScienceDirect Journals</source><source>PubMed Central</source><creator>de Carvalho, Mamede ; Swash, Michael</creator><creatorcontrib>de Carvalho, Mamede ; Swash, Michael</creatorcontrib><description>•Accurate and rapid diagnosis of amyotrophic lateral sclerosis (ALS) is important to prevent erroneous interventions.•The recent Gold Coast criteria are easily applicable and have high sensitivity and specificity.•Future developments will help to distinguish ALS as a specific clinical-pathologic entity. Accurate and rapid diagnosis of amyotrophic lateral sclerosis (ALS) is essential in order to provide accurate information for patient and family, to avoid time-consuming investigations and to permit an appropriate management plan. ALS is variable regarding presentation, disease progression, genetic profile and patient reaction to the diagnosis. It is obviously important to exclude treatable conditions but, in most patients, for experienced neurologists the diagnosis is clear-cut, depending on the presence of progressive upper and lower motor neuron signs. Patients with signs of restricted lower motor neuron (LMN) or upper motor neuron (UMN) dysfunction may present diagnostic difficulty, but electromyography (EMG) is often a determinant diagnostic test since it may exclude other disorders. Transcranial magnetic stimulation may aid detection of UMN dysfunction, and brain and spinal cord MRI, ultrasound and blood neurofilament measurements, have begun to have clinical impact, although none are themselves diagnostic tests. Several sets of diagnostic criteria have been proposed in the past; all rely on clinical LMN and UMN signs in different anatomic territories, EMG changes, exclusion of other disorders, and disease progression, in particular evidence of spreading to other anatomic territories. Fasciculations are a characteristic clinical feature and increased importance is now attached to fasciculation potentials detected by EMG, when associated with classical signs of denervation and reinnervation. The Gold Coast diagnostic criteria rely on the presence of UMN and LMN signs in one (or more) anatomic territory, or LMN signs in two (or more) anatomic territories, recognizing the fundamental clinical requirements of disease progression and exclusion of other diseases. Recent studies confirm a high sensitivity without loss of specificity using these Gold Coast criteria. In considering the diagnosis of ALS a critical question for future understanding is whether ALS should be considered a syndrome or a specific clinico-pathologic entity; this can only be addressed in the light of more complete knowledge.</description><identifier>ISSN: 2467-981X</identifier><identifier>EISSN: 2467-981X</identifier><identifier>DOI: 10.1016/j.cnp.2023.12.003</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Amyotrophic Lateral Sclerosis ; Diagnostic criteria ; Differential diagnosis ; Electromyography ; Motor neuron disease</subject><ispartof>Clinical neurophysiology practice, 2024, Vol.9, p.27-38</ispartof><rights>2023 International Federation of Clinical Neurophysiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c391t-a7aeb296c96c04f42b13269ec9d543b2e5247c723b45b6a093a80f11c259af7d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2467981X23000355$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,4024,27923,27924,27925,45780</link.rule.ids></links><search><creatorcontrib>de Carvalho, Mamede</creatorcontrib><creatorcontrib>Swash, Michael</creatorcontrib><title>Diagnosis and differential diagnosis of MND/ALS: IFCN handbook chapter</title><title>Clinical neurophysiology practice</title><description>•Accurate and rapid diagnosis of amyotrophic lateral sclerosis (ALS) is important to prevent erroneous interventions.•The recent Gold Coast criteria are easily applicable and have high sensitivity and specificity.•Future developments will help to distinguish ALS as a specific clinical-pathologic entity. Accurate and rapid diagnosis of amyotrophic lateral sclerosis (ALS) is essential in order to provide accurate information for patient and family, to avoid time-consuming investigations and to permit an appropriate management plan. ALS is variable regarding presentation, disease progression, genetic profile and patient reaction to the diagnosis. It is obviously important to exclude treatable conditions but, in most patients, for experienced neurologists the diagnosis is clear-cut, depending on the presence of progressive upper and lower motor neuron signs. Patients with signs of restricted lower motor neuron (LMN) or upper motor neuron (UMN) dysfunction may present diagnostic difficulty, but electromyography (EMG) is often a determinant diagnostic test since it may exclude other disorders. Transcranial magnetic stimulation may aid detection of UMN dysfunction, and brain and spinal cord MRI, ultrasound and blood neurofilament measurements, have begun to have clinical impact, although none are themselves diagnostic tests. Several sets of diagnostic criteria have been proposed in the past; all rely on clinical LMN and UMN signs in different anatomic territories, EMG changes, exclusion of other disorders, and disease progression, in particular evidence of spreading to other anatomic territories. Fasciculations are a characteristic clinical feature and increased importance is now attached to fasciculation potentials detected by EMG, when associated with classical signs of denervation and reinnervation. The Gold Coast diagnostic criteria rely on the presence of UMN and LMN signs in one (or more) anatomic territory, or LMN signs in two (or more) anatomic territories, recognizing the fundamental clinical requirements of disease progression and exclusion of other diseases. Recent studies confirm a high sensitivity without loss of specificity using these Gold Coast criteria. In considering the diagnosis of ALS a critical question for future understanding is whether ALS should be considered a syndrome or a specific clinico-pathologic entity; this can only be addressed in the light of more complete knowledge.</description><subject>Amyotrophic Lateral Sclerosis</subject><subject>Diagnostic criteria</subject><subject>Differential diagnosis</subject><subject>Electromyography</subject><subject>Motor neuron disease</subject><issn>2467-981X</issn><issn>2467-981X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9UctOwzAQjBBIIOgHcMuRS4MfSRzDCRUKlQocAImbtXbW4JLGxQ5I_D0uBcQJabUPe2bW8mTZISUFJbQ-XhSmXxWMMF5QVhDCt7I9VtZiLBv6uP2n381GMS4IIVSQdd7LpucOnnofXcyhb_PWWYsB-8FBl4afK2_z65vz47P53Uk-m05u8ucE1t6_5OYZVgOGg2zHQhdx9F33s4fpxf3kajy_vZxNzuZjwyUdxiAANZO1SUFKWzJNOaslGtlWJdcMK1YKIxjXZaVrIJJDQyylhlUSrGj5fjbb6LYeFmoV3BLCh_Lg1NeBD08KwuBMh4qWDCowWgqiSyla2XBdNxw5tFZbWyeto43WKvjXN4yDWrposOugR_8WFZNUVFXDKEtQuoGa4GMMaH9XU6LWFqiFShaotQWKMpUsSJzTDQfTf7w7DCoah73B1gU0Q3qw-4f9CafJjHU</recordid><startdate>2024</startdate><enddate>2024</enddate><creator>de Carvalho, Mamede</creator><creator>Swash, Michael</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>2024</creationdate><title>Diagnosis and differential diagnosis of MND/ALS: IFCN handbook chapter</title><author>de Carvalho, Mamede ; Swash, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-a7aeb296c96c04f42b13269ec9d543b2e5247c723b45b6a093a80f11c259af7d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Amyotrophic Lateral Sclerosis</topic><topic>Diagnostic criteria</topic><topic>Differential diagnosis</topic><topic>Electromyography</topic><topic>Motor neuron disease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Carvalho, Mamede</creatorcontrib><creatorcontrib>Swash, Michael</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Clinical neurophysiology practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Carvalho, Mamede</au><au>Swash, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnosis and differential diagnosis of MND/ALS: IFCN handbook chapter</atitle><jtitle>Clinical neurophysiology practice</jtitle><date>2024</date><risdate>2024</risdate><volume>9</volume><spage>27</spage><epage>38</epage><pages>27-38</pages><issn>2467-981X</issn><eissn>2467-981X</eissn><abstract>•Accurate and rapid diagnosis of amyotrophic lateral sclerosis (ALS) is important to prevent erroneous interventions.•The recent Gold Coast criteria are easily applicable and have high sensitivity and specificity.•Future developments will help to distinguish ALS as a specific clinical-pathologic entity. Accurate and rapid diagnosis of amyotrophic lateral sclerosis (ALS) is essential in order to provide accurate information for patient and family, to avoid time-consuming investigations and to permit an appropriate management plan. ALS is variable regarding presentation, disease progression, genetic profile and patient reaction to the diagnosis. It is obviously important to exclude treatable conditions but, in most patients, for experienced neurologists the diagnosis is clear-cut, depending on the presence of progressive upper and lower motor neuron signs. Patients with signs of restricted lower motor neuron (LMN) or upper motor neuron (UMN) dysfunction may present diagnostic difficulty, but electromyography (EMG) is often a determinant diagnostic test since it may exclude other disorders. Transcranial magnetic stimulation may aid detection of UMN dysfunction, and brain and spinal cord MRI, ultrasound and blood neurofilament measurements, have begun to have clinical impact, although none are themselves diagnostic tests. Several sets of diagnostic criteria have been proposed in the past; all rely on clinical LMN and UMN signs in different anatomic territories, EMG changes, exclusion of other disorders, and disease progression, in particular evidence of spreading to other anatomic territories. Fasciculations are a characteristic clinical feature and increased importance is now attached to fasciculation potentials detected by EMG, when associated with classical signs of denervation and reinnervation. The Gold Coast diagnostic criteria rely on the presence of UMN and LMN signs in one (or more) anatomic territory, or LMN signs in two (or more) anatomic territories, recognizing the fundamental clinical requirements of disease progression and exclusion of other diseases. Recent studies confirm a high sensitivity without loss of specificity using these Gold Coast criteria. In considering the diagnosis of ALS a critical question for future understanding is whether ALS should be considered a syndrome or a specific clinico-pathologic entity; this can only be addressed in the light of more complete knowledge.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.cnp.2023.12.003</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2467-981X
ispartof Clinical neurophysiology practice, 2024, Vol.9, p.27-38
issn 2467-981X
2467-981X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_142a5acb970b497d983b683e3adfbff6
source Elsevier ScienceDirect Journals; PubMed Central
subjects Amyotrophic Lateral Sclerosis
Diagnostic criteria
Differential diagnosis
Electromyography
Motor neuron disease
title Diagnosis and differential diagnosis of MND/ALS: IFCN handbook chapter
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A19%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnosis%20and%20differential%20diagnosis%20of%20MND/ALS:%20IFCN%20handbook%20chapter&rft.jtitle=Clinical%20neurophysiology%20practice&rft.au=de%20Carvalho,%20Mamede&rft.date=2024&rft.volume=9&rft.spage=27&rft.epage=38&rft.pages=27-38&rft.issn=2467-981X&rft.eissn=2467-981X&rft_id=info:doi/10.1016/j.cnp.2023.12.003&rft_dat=%3Cproquest_doaj_%3E2917558212%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c391t-a7aeb296c96c04f42b13269ec9d543b2e5247c723b45b6a093a80f11c259af7d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2917558212&rft_id=info:pmid/&rfr_iscdi=true